The adoption of biosimilars in Oxford: a case study

Identifying the optimal means of introducing biosimilars is an issue facing all clinics. Biosimilar rituximab was introduced in Oxford, UK in August 2017. Here, Nicola Stoner, BSc, PhD, MRPharmS, SPre... Author: VJHemOnc Added: 01/18/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts